Detecting and Destroying Cancer Cells in More than One Way with Noble Metals and Different Confinement Properties on the Nanoscale

Abstract

CONSPECTUS Today, 1 in 2 males and 1 in 3 females in the US will develop cancer at some point during their lifetimes, and 1 in 4 males and 1 in 5 females in the U.S. will die from the disease. New methods for detection and treatment have dramatically improved cancer care in the United States. However, as improved detection and increasing exposure to carcinogens has led to higher rates of cancer incidence, clinicians and researchers have not balanced that increase with a similar decrease in cancer mortality rates. This mismatch highlights a clear and urgent need for increasingly potent and selective methods with which to detect and treat cancers at their earliest stages. Nanotechnology, the use of materials with structural features ranging from 1 to 100 nm in size, has dramatically altered the design, use, and delivery of cancer diagnostic and therapeutic agents. The unique and newly discovered properties of these structures can enhance the specificities with which biomedical agents are delivered, complementing their efficacy or diminishing unintended side effects. Gold (and silver) nanotechnologies afford a particularly unique set of physiological and optical properties which can be leveraged in applications ranging from in vitro/vivo therapeutics and drug delivery to imaging and diagnostics, surgical guidance, and treatment monitoring. Nanoscale diagnostic and therapeutic agents have been in use since the development of micellar nanocarriers and polymer-drug nanoconjugates in the mid-1950s, liposomes by Bangham and Watkins the mid-1960s, and the introduction of polymeric nanoparticles by Langer and Folkman in 1976. Since then, nanoscale constructs such as dendrimers, protein nanoconjugates, and inorganic nanoparticles have been developed for the systemic delivery of agents to specific disease sites. Today, more than 20 FDA-approved diagnostic or therapeutic nanotechnologies are in clinical use with roughly 250 others are in clinical development. The global market for nano-enabled medical technologies is expected to grow to $70-160 billion by 2015, rivaling the current market share of biologics worldwide. In this Account, we explore the emerging applications of noble metal nanotechnologies in cancer diagnostics and therapeutics carried out by our group and by others. Many of the novel biomedical properties associated with gold and silver nanoparticles arise from confinement effects: i) the confinement of photons within the particle which can lead to dramatic electromagnetic scattering and absorption (useful in sensing and heating applications, respectively); ii) the confinement of molecules around the nanoparticle (useful in drug delivery); and iii) the cellular/subcellular confinement of particles within malignant cells (such as selective, nuclear-targeted cytotoxic DNA damage by gold nanoparticles). We then describe how these confinement effects relate to specific aspects of diagnosis and treatment such as: i) laser photothermal therapy, optical scattering microscopy, and spectroscopic detection, ii) drug targ...

Real-time in vivo imaging of size-dependent transport and toxicity of gold nanoparticles in zebrafish embryos using single nanoparticle plasmonic spectroscopy

“…Despite extensive study of Au NPs and their potential applications in biology and medicine [23,24], their effects on living organisms and their dependence upon physicochemical properties of the NPs still remain largely unknown [25][26][27][28].…”

Probing molecular cell event dynamics at the single-cell level with targeted plasmonic gold nanoparticles: A review

“…cancerous) cell state from a healthy cell population [101,102]. Our group, in particular, has employed enhanced Rayleigh scattering and plasmonically enhanced Raman scattering from AuNPs to not only identify human oral cancer cells, but also to selectively destroy them with AuNP assisted photothermal therapy [64,103,104].…”

Anisotropic Gold Nanoparticles: Preparation, Properties, and Applications

“…Besides AuNRs, other shapes of anisotropic AuNPs also have advantages for biosensors [224]. Au nanopyramids, nanotubes, nanocages, nanowires, nanostars and Au@Ag NRs have been reported as biosensors and bioprobes [225].…”